Sahar A Elsayed1, Mohamed A Esmail2, Randa M Ali2, Omar M Mohafez3. 1. Department of Rheumatology and Rehabilitation, Faculty of Medicine, Sohag University, Sohag, Egypt. saharomar2000@yahoo.co.uk. 2. Department of Rheumatology and Rehabilitation, Faculty of Medicine, Sohag University, Sohag, Egypt. 3. Department of Biochemistry, Faculty of Pharmacy, Assiut Branch Al-Azhar University, Asyut, Egypt.
Abstract
INTRODUCTION: Detection of autoantibodies in sera of rheumatoid arthritis (RA) patients has an important role in diagnosis and management strategies. Recently, another type of autoantibodies has been detected with activity against carbamylated proteins (anti-CarP) which may play an important role in the diagnosis of RA. The aim of this study was to raise knowledge about the diagnostic and prognostic value of anti-CarP antibodies in RA. MATERIALS AND METHODS: Seventy RA patients and thirty-four controls were included in this study. DAS28 was used to evaluate disease activity. Joint erosions were assessed by Larsen score using plain X-ray of involved joints of hands and feet. Serum samples were analyzed for anti-CarP antibody titer using the ELISA technique. RESULTS: Out of 70 patients, 35.7% were positive for anti-CarP and only 5.88% of controls had high titer above the cut-off value. A total of 24.29% of the patients were RF-negative and 30% were ACPA-negative. Five patients (29.41%) of the negative RF group were positive for anti-CarP. Four patients (19%) of the ACPA-negative group were positive for anti-CarP, and three patients (4.28%) of the total number of patients were triple negative and seventeen (24.28%) were triple positive. There was a significant correlation between anti-CarP titer and both DAS28 and Larsen scores only in the positive anti-CarP group. In addition, there was a strong association between anti-CarP antibody titer and joint erosions at both baseline and after 1-year follow-up. CONCLUSION: Presence of the anti-CarP antibodies in sera of RA patients may have a prognostic value as it correlates with the disease activity and joint erosions; moreover, it may have a diagnostic value in rheumatoid arthritis especially in RF- and ACPA-negative patients. Key Points • This study was carried out to raise our knowledge about the importance of anti-CarP antibodies in predicting the prognosis of RA. • This study was carried out to assess the correlation between anti-CarP antibodies, disease activity, and joint erosions. • This study was carried out to state the extent to which we can rely on the anti-CarP antibodies as a biomarker for prediction of RA.
INTRODUCTION: Detection of autoantibodies in sera of rheumatoid arthritis (RA) patients has an important role in diagnosis and management strategies. Recently, another type of autoantibodies has been detected with activity against carbamylated proteins (anti-CarP) which may play an important role in the diagnosis of RA. The aim of this study was to raise knowledge about the diagnostic and prognostic value of anti-CarP antibodies in RA. MATERIALS AND METHODS: Seventy RApatients and thirty-four controls were included in this study. DAS28 was used to evaluate disease activity. Joint erosions were assessed by Larsen score using plain X-ray of involved joints of hands and feet. Serum samples were analyzed for anti-CarP antibody titer using the ELISA technique. RESULTS: Out of 70 patients, 35.7% were positive for anti-CarP and only 5.88% of controls had high titer above the cut-off value. A total of 24.29% of the patients were RF-negative and 30% were ACPA-negative. Five patients (29.41%) of the negative RF group were positive for anti-CarP. Four patients (19%) of the ACPA-negative group were positive for anti-CarP, and three patients (4.28%) of the total number of patients were triple negative and seventeen (24.28%) were triple positive. There was a significant correlation between anti-CarP titer and both DAS28 and Larsen scores only in the positive anti-CarP group. In addition, there was a strong association between anti-CarP antibody titer and joint erosions at both baseline and after 1-year follow-up. CONCLUSION: Presence of the anti-CarP antibodies in sera of RApatients may have a prognostic value as it correlates with the disease activity and joint erosions; moreover, it may have a diagnostic value in rheumatoid arthritis especially in RF- and ACPA-negative patients. Key Points • This study was carried out to raise our knowledge about the importance of anti-CarP antibodies in predicting the prognosis of RA. • This study was carried out to assess the correlation between anti-CarP antibodies, disease activity, and joint erosions. • This study was carried out to state the extent to which we can rely on the anti-CarP antibodies as a biomarker for prediction of RA.
Entities:
Keywords:
Anti-CarP antibodies in rheumatoid arthritis; Assessment of disease activity; Relation of autoantibodies with joint erosions
Authors: Jing Shi; Rachel Knevel; Parawee Suwannalai; Michael P van der Linden; George M C Janssen; Peter A van Veelen; Nivine E W Levarht; Annette H M van der Helm-van Mil; Anthony Cerami; Tom W J Huizinga; Rene E M Toes; Leendert A Trouw Journal: Proc Natl Acad Sci U S A Date: 2011-10-10 Impact factor: 11.205
Authors: I E A Hoffman; I Peene; L Cebecauer; D Isenberg; T W J Huizinga; A Union; L Meheus; K De Bosschere; F Hulstaert; E M Veys; F De Keyser Journal: Ann Rheum Dis Date: 2005-02 Impact factor: 19.103
Authors: Lílian Santuza Santos Porto; Wilson Campos Tavares; Dário Alves da Silva Costa; Cristina Costa Duarte Lanna; Adriana Maria Kakehasi Journal: Rev Bras Reumatol Engl Ed Date: 2015-12-02
Authors: Leonie E Burgers; Hanna W van Steenbergen; Robin M Ten Brinck; Tom Wj Huizinga; Annette Hm van der Helm-van Mil Journal: Ann Rheum Dis Date: 2017-06-12 Impact factor: 19.103
Authors: S Ajeganova; H W van Steenbergen; M K Verheul; K Forslind; I Hafström; R E M Toes; T W J Huizinga; B Svensson; L A Trouw; A H M van der Helm-van Mil Journal: Ann Rheum Dis Date: 2016-04-26 Impact factor: 19.103
Authors: Emma C de Moel; Veerle F A M Derksen; Leendert A Trouw; Holger Bang; Gerard Collée; Leroy R Lard; Sofia Ramiro; Tom W J Huizinga; Cornelia F Allaart; René E M Toes; Diane van der Woude Journal: Arthritis Res Ther Date: 2019-01-18 Impact factor: 5.156
Authors: Liam J O'Neil; Ana Barrera-Vargas; Donavon Sandoval-Heglund; Javier Merayo-Chalico; Eduardo Aguirre-Aguilar; Angel M Aponte; Yanira Ruiz-Perdomo; Marjan Gucek; Hani El-Gabalawy; David A Fox; James D Katz; Mariana J Kaplan; Carmelo Carmona-Rivera Journal: Sci Adv Date: 2020-10-28 Impact factor: 14.136